Research & Development: Page 62
-
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Formulary Decision Makers Want Digital Resources from Pharma Companies Lose Revenue to Nonadherence Contract Sales to Grow KOL Advocacy is Critical Sidebar: Nonadherence Study Highlights Thought Leader Pool Shrinking as ...
By Taren Grom • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies Trending Now: As trials become larger and more complex, enhancing efficiency and traceability of clinical trial inventory is critical. PharmaVigilant has released I-Accountability, a drug accountability system that efficiently tra...
By Taren Grom • Jan. 25, 2013 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Publicis Healthcare Communications Group Launches Publicis Health Media Havas Health Launches New Global Agency Group INC Research Expands Global Consulting Capabilities Cenduit Introduces New Clinical Trial Supply Simulati...
By Taren Grom • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
CHILE: Opportunities and Challenges
Chile is considered to be Latin America’s economic powerhouse, but it is a forgotten paradise some say because it is the most politically and economically stable country in Latin America and doesn’t generate the headlines of some of its neighbors. The Pharmaceutical Landscape Geographically ancho...
By Taren Grom • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
ACOs: A New Health Model for a New World
How healthcare is delivered to Medicare patients is changing as a result of the Affordable Care Act (ACA) of 2010. Accountable care organizations (ACOs) are groups of providers that aim to provide integrated and coordinated care to Medicare patients that is driven by outcomes, and, if successful,...
By Denise Myshko • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Soft Metrics Uncover Medical Publications’ True Value Use of Efficacy and Effectiveness May Skew Reimbursement Decisions Extraneous Data Collected in Clinical Trials Cost Drug Developers Leading Biosimilar Companies Expe...
By Denise Myshko • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Symphony Health Solutions Launches ePrescribing Solutions Suite Optum Accelerates Late-Phase Research E-UPGRADES AND ENHANCEMENTS In other technology news Source Healthcare Analytics, a Symphony Health Solutions c...
By Denise Myshko • Dec. 27, 2012 -
PharmaVoice Team/PharmaVoice
Experts: Thought Leaders
Mike Ackermann, Ph.D. Senior VP, Global Commercial Solutions, Quintiles, a biopharmaceutical services company offering fully integrated clinical, commercial, consulting, and capital solutions. For more information, visit quintiles.com. Faraz Ali. VP, Program Management and Commercial Planning, b...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
Global: Markets
The Continued Influence of Global Markets Across all aspects of the business, the life-sciences industry can no longer afford to think and act locally. From changing demographics, emerging markets increasing in influence, and an increasing focus on both biotech products and generics, pharmaceutic...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: Regulatory
Pharmaceutical Regulations Become More Challenging As pharmaceutical regulations become more complex globally, regulatory professionals are challenged to stay abreast of new regulations to remain compliant. Now more than ever, global health authorities are looking for a comprehensive risk managem...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: Outsourcing
Outsourcing Becomes Strategic Pharma and biotech companies are now looking to their outsourcing partners to also weigh in on critical strategic and execution decisions. Cost, time to market, and risk are causing more companies to reduce their reliance on internal R&D for innovation. Outsourci...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: Technology
Technology in Clinical Trials Data are the lifeblood of a clinical trial, yet more information isn’t always the answer to improved productivity. Data are the glue that hold clinical trials together, says Colin Hill, CEO, president, chairman, and co-founder of GNS Healthcare. “Data are being creat...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
R&D: Protocols
Optimizing Clinical Trials Experts say optimizing the various processes in clinical development is critical for the timely and efficient approval of new products. Over the past several years pharmaceutical companies have been facing increases in costs and delays in conducting their clinical trial...
By Denise Myshko • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
The C-Suite: Corporate Strategies
A New Path Ahead According to a recent Quintiles New Health report, a lack of capital and the increased reluctance of payers to reimburse for new medications are serious concerns among biopharma companies. Everyone is in agreement that the current level of healthcare spending is unsustainable, an...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Social Media, Mobile & Gaming for Pharma: How To Develop, Monitor, & Execute Digital Strategies To Engage Your Audiences, Strengthen Brand Awareness & Maximize Your Communication & Marketi...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Honored by Working Mother Bayer has been recognized by Working Mother magazine as one of the nation’s 100 best companies for working mothers. This is the ninth time in the past 10 years the company has been recognized on the annual list Clinical Research Advantage Executive Honorod Clinic...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Volume 12 • Number 10 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing Editor Denise Myshko Senior Editor Robin Features Editor Kim Ribbink Contributing Editor Carolyn Gretton Design Associate Ariel Medel National Account Managers Trish Kane, Cathy Tracy WEBCAST?NETW...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
China's Pharma Star Shines Bright
With a large patient population, government commitment to healthcare reform, a huge depth of scientific talent, and a powerful economy, China has been identified by many as the world’s most important emerging biopharma market. With a population of 1.3 billion people, China is both the world’s mos...
By Kim Ribbink • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Last Word
Developing a Patient-Centric Business Model Rob Bazemore, President of Janssen Biotech, discusses why and how the company is implementing a patient-centric focus throughout all levels of the company. PV: What does being patient-centric mean for Janssen Biotech? Bazemore: Patients are our top pri...
By Rob Basemore • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, M.D., has joined Infinity Pharmaceuticals as executive VP, chief financial officer, and chief business officer. Dr. Bloch is responsible for the company’s corporate, financial, and business development strategies...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Long Goodbye: Alzheimer’s Disease The numbers are almost as daunting as Alzheimer’s disease itself. Today, 5.4 million Americans are living with the disease. Every four seconds around the world, someone is diagnosed with dementia. According to Alzheimer’s Disease International, there are 7.7 ...
By Taren Grom • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Data Management and Functional Outsourcing
Mark Penniston, Senior VP & General Manager, Clinical Analytics, Theorem Clinical Research. Theorem Clinical Research is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of th...
By Mark Penniston • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
A single, Common User Identity: The Door to an Optimized User Experience
A Single, Common User Identity: The Door to an Optimized User Experience Investigators involved in clinical trials will tell you how important single sign-on would be to them. Speaking with investigational sites involved in multiple trials, they explain how operating multiple technology solutions...
By Bill Byrom • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Key Data Management Strategies for Successful Late-Phase Studies
Late-phase studies present a set of unique goals and challenges unlike those in earlier phase clinical trials. Because this brand of research strives to reflect the real world, study designs are varied, data may be unavailable, and the uncontrolled environment may present unexpected results. At t...
By Steve Gulyas • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Preparing for Big Data: Laying the Foundation with Master Data Management
Preparing for Big Data: Laying the Foundation with Master Data Management Experts John Busalacchi, Senior Principal, IMS?Health. IMS Health is a leading provider of information, services and technology for the healthcare industry, covering markets in 100-plus countries around the world. For mor...
By John Busalacchi Senior Principal • Aug. 31, 2012
Previous
